Close Menu

NEW YORK – Veritas Genetics is shutting down its US operations, at least temporarily, due to financial troubles.

Mirza Cifric, the company's CEO, told GenomeWeb that the firm ran out of funds because a planned financing fell through, which was "very abrupt and unexpected," and that it started laying off most of its US staff, more than 30 employees, earlier this week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.